Lecigon

Entacapone, Levodopa, Carbidopa, the active ingredient in Lecigon, is a Levodopa/Carbidopa/Entacapone combination presented as an oral tablet formulation for oral use. It is indicated for the management of Parkinson's disease and helps reduce motor fluctuations in patients requiring dopaminergic therapy. GNH USA supplies Lecigon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lecigon is a Levodopa/Carbidopa/Entacapone combination used in the Parkinson's disease treatment pathway. - Parkinson's disease: improves motor control and reduces OFF episodes. - Parkinson's disease with motor fluctuations: extends duration of ON time. - Parkinson's disease: enhances overall functional ability and daily activities.

Lecigon may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Dizziness or light‑headedness: often related to orthostatic changes. - Headache: transient and usually resolves. - Insomnia: difficulty initiating or maintaining sleep. - Dyskinesia: involuntary movements, especially at higher levodopa doses. - Orthostatic hypotension: drop in blood pressure upon standing.

Serious or Rare Side Effects: - Severe liver injury: elevated transaminases or hepatitis. - Neuroleptic malignant syndrome: high fever, rigidity, autonomic instability. - Severe depression or suicidal thoughts: monitor mental health closely. - Allergic reactions: rash, angioedema, or anaphylaxis. - Hallucinations or psychosis: especially in older patients. - Cardiac arrhythmias: rare but possible with concomitant drugs.

When prescribing or dispensing Lecigon, consider the following precautions. - Monitor blood pressure: watch for orthostatic hypotension, especially after dose initiation. - Assess liver function: entacapone may affect hepatic enzymes; periodic testing is advised. - Evaluate psychiatric status: be alert for depression, hallucinations, or suicidal ideation. - Adjust dose in renal impairment: consider renal function when titrating therapy. - Avoid abrupt discontinuation: sudden stop may worsen Parkinsonian symptoms. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Lecigon interacts with several medication classes.

Major Interactions (Avoid): - Non‑selective MAO inhibitors: risk of hypertensive crisis. - Anticholinergic agents: may diminish levodopa efficacy. - CNS depressants: increased sedation and respiratory depression.

Moderate Interactions (Monitor Closely): - Antihypertensive drugs: may potentiate hypotensive effects. - SSRIs or SNRIs: potential for serotonin syndrome. - Iron or calcium supplements: can reduce levodopa absorption; separate dosing by at least 2 hours.